Osaic Holdings’s aTyr Pharma ATYR Stock Holding History

Osaic Holdings’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,000	Closed	-$3.9K	–	8210
2026 Q1	$3.9K	Buy	+5,000	New	+$4.22K	﹤0.01%	6798
2021 Q4	–	Sell	-1	Closed	–	–	7615
2021 Q3	$0	Buy	+1	New	+$6	﹤0.01%	7345

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings's ATYR Position: Q2 2026 in Review

Osaic Holdings sold out of aTyr Pharma (ATYR) in Q2 2026, closing a stake of 5,000 shares — an estimated $3.9K sold.

Osaic Holdings first reported a position in ATYR in Q3 2021 and held it in 2 quarters. The position peaked at $3.9K in Q1 2026. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

Osaic Holdings reported no remaining aTyr Pharma position as of Q2 2026 after selling out during the quarter.
Osaic Holdings sold 5,000 aTyr Pharma shares in Q2 2026, an estimated $3.9K.
Osaic Holdings first reported a position in aTyr Pharma in Q3 2021 and held it in 2 quarters.
Osaic Holdings's aTyr Pharma position peaked at $3.9K in Q1 2026.
90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.